Evidence map›Paper›PMID 41501761›Full record

ArticleBMC endocrine disorders2026

Association between the WHO 2017 and 2022 classification updates and ICD-10 code accuracy in patients with PitNETs: a real-world retrospective study.

Jingya Zhou, Xiaopeng Guo, Xinxin Mao, Lian Duan, Aimin Liao, Naishi Li, Bing Xing

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jingya Zhou *Department of Medical Records, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Collaborating Center for the WHO Family of International Classifications in China, Beijing, China.
Xiaopeng Guo *Department of Neurosurgery, Key Laboratory of Endocrinology of National Health Commission of People's Republic of China, China Pituitary Adenoma Specialist Council, China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xinxin MaoDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lian DuanDepartment of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College, Key Laboratory of Endocrinology of National Health Commission of People's Republic of China, Beijing, China.
Aimin LiaoDepartment of Medical Records, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Collaborating Center for the WHO Family of International Classifications in China, Beijing, China.
Naishi LiDepartment of Medical Records, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Collaborating Center for the WHO Family of International Classifications in China, Beijing, China. LNS@medmail.com.cn.
Bing XingDepartment of Neurosurgery, Key Laboratory of Endocrinology of National Health Commission of People's Republic of China, China Pituitary Adenoma Specialist Council, China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. xingbingemail@aliyun.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was conducted to evaluate the association between the implementation of the WHO 2017 and 2022 classification updates for pituitary tumours and the validity of ICD-10 codes in identifying nonfunctioning and functioning subtypes of pituitary neuroendocrine tumours (PitNETs) in a real-world surgical cohort.

methodsWe analysed data from 1,096 surgically treated PitNET patients at a major Chinese medical centre between January 2020 and April 2024. The validity of the ICD-10 codes for identifying nonfunctioning and functioning PitNET subtypes was assessed using prepathological discharge diagnoses as the reference standard. The performance metrics, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Youden index, F1 score, and kappa statistic, were calculated for each subtype. These validity measures were then compared between cases classified according to the 2017/2022 WHO criteria and those classified using the pre-2017 criteria in pathological reports.

resultsICD-10 code sensitivity was lowest for nonfunctioning PitNETs (72.9%; 95% CI: 69.1-76.3), followed by functioning gonadotrophs (83.3%; 95% CI: 36.5-99.1) and corticotrophs (84.0%; 95% CI: 77.4-89.0), while other subtypes maintained high sensitivity (97.9%-100%). Most subtypes had low PPVs (6.3-75.0%), except for nonfunctioning and somatotroph PitNETs. The nonfunctioning PitNET code also had a low NPV (73.8%; 95% CI: 70.1-77.2). When cases were pathologically classified using the updated 2017/2022 WHO criteria, a substantial decrease in sensitivity for nonfunctioning PitNETs was observed (94.7% to 63.0%, p < 0.001), which coincided with a reduced NPV, F1 score, and kappa, despite increased specificity (95.8% vs. 86.8%, p < 0.01). Similarly, under the new classification, corticotroph PitNETs had decreased specificity (100.0% to 92.8%, p < 0.001), PPV (94.8% to 64.6%, p < 0.001), and composite metrics. Notably, low PPVs persisted for lactotroph (59.2%) and gonadotroph (5.1%) PitNETs. Coding discrepancies primarily involved confusion with new pathological terminology and misapplication of endocrine codes for pituitary stalk compression effects.

conclusionThe updated WHO classifications enhance pathological detail but should not guide clinical ICD coding, as misapplication reduces coding accuracy in surgically managed PitNETs. Future frameworks must align pathological nomenclature with clinical endocrine function in the ICD, maintaining a clear distinction between these domains. Multidisciplinary collaboration and standardized coding protocols are essential for improving accuracy. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

International Classification of DiseasesNeuroendocrine TumorsPituitary NeoplasmsAdultFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesSensitivity and SpecificityWorld Health OrganizationAccuracyImmunohistochemistryInternational classification of diseasePituitary adenomaPituitary neuroendocrine tumour

Identifiers

PMID41501761
PMCPMC12870912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.